Treatment-resistant inflammatory myopathy

Best Pract Res Clin Rheumatol. 2010 Jun;24(3):427-40. doi: 10.1016/j.berh.2009.12.008.

Abstract

When confronted with a dermatomyositis or polymyositis patient not responding to immunosuppressive treatment, physicians must first ask whether the original diagnosis was correct. In this review, we provide a guide to the clinical features and ancillary tests, which might be helpful in the differential diagnosis of myositis. Particular attention is paid to the role of autoantibody detection, as some of them are not only relatively specific for the disease but also associated with unique clinical features including resistance to treatment. Subsequently, other possible explanations of treatment resistance are listed and a short overview of treatment options for resistant myositis patients is given.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Dermatomyositis / diagnosis*
  • Dermatomyositis / drug therapy
  • Dermatomyositis / immunology
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Polymyositis / diagnosis*
  • Polymyositis / drug therapy
  • Polymyositis / immunology
  • Treatment Failure

Substances

  • Immunosuppressive Agents